Drug Discovery

Scientists at ETH Zurich identified a new Alzheimer's trigger and developed an experimental compound that slowed nerve cell loss and extended lifespan in mice.

Researchers developed a light-powered method to create high-energy "housane" molecules, which are valuable for drug development and materials science.